Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Diagn Interv Radiol. 2020 May;26(3):176-182. doi: 10.5152/dir.2019.19375.
Gastric cancer is the fifth most common malignancies and the third leading cause of cancer-related death worldwide, with more than 40% of new cases occurring in China. With the advancement of treatment methods, the application of adjuvant therapy and targeted drugs, the prognosis of patients with gastric cancer has been significantly improved. In recent years, more and more studies have reported that magnetic resonance imaging (MRI) showed great value in the clinical application among patients with gastric cancer, including preoperative staging, treatment response evaluation, predicting prognosis and histopathological features, treatment guidance, and molecular imaging. The remarkable research progress of MRI in gastric cancer will provide new evaluation and treatment approaches for clinical diagnosis and treatment. This article aims to review the current status of the application and research progress of MRI in patients with gastric cancer.
胃癌是全球第五大常见恶性肿瘤，也是癌症相关死亡的第三大主要原因，超过 40%的新发病例发生在中国。随着治疗方法的进步，辅助治疗和靶向药物的应用，胃癌患者的预后得到了显著改善。近年来，越来越多的研究报告称，磁共振成像（MRI）在胃癌患者的临床应用中具有重要价值，包括术前分期、治疗反应评估、预测预后和组织病理学特征、治疗指导和分子成像。MRI 在胃癌中的显著研究进展将为临床诊断和治疗提供新的评估和治疗方法。本文旨在综述 MRI 在胃癌患者中的应用及研究进展现状。
Diagn Interv Radiol. 2020-5
Zhonghua Wei Chang Wai Ke Za Zhi. 2016-2
Zhonghua Wei Chang Wai Ke Za Zhi. 2018-10-25
Surg Pract Sci. 2025-5-29
World J Gastroenterol. 2025-2-14
Cell Biol Toxicol. 2024-11-20
World J Gastroenterol. 2024-11-7
World J Gastrointest Oncol. 2024-9-15
Bioengineering (Basel). 2024-8-8
Radiat Oncol. 2019-6-3
Gastroenterol Res Pract. 2019-2-3
Zotero 插件